Neuroimagen Molecular
Karolinska University Hospital
Estocolmo, SueciaPublicaciones en colaboración con investigadores/as de Karolinska University Hospital (7)
2021
-
Biomarker counseling, disclosure of diagnosis and follow-up in patients with mild cognitive impairment: A European Alzheimer's disease consortium survey
International Journal of Geriatric Psychiatry, Vol. 36, Núm. 2, pp. 324-333
2018
-
Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington’s disease
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 45, Núm. 9, pp. 1546-1556
2017
-
Emerging clinical issues and multivariate analyses in PET investigations
Quarterly Journal of Nuclear Medicine and Molecular Imaging, Vol. 61, Núm. 4, pp. 386-404
-
Erratum to: The need of standardization and of large clinical studies in an emerging indication of [18F]FDG PET: the autoimmune encephalitis (European Journal of Nuclear Medicine and Molecular Imaging, (2017), 44, 3, (353-357), 10.1007/s00259-016-3589-9)
European Journal of Nuclear Medicine and Molecular Imaging
-
The need of standardization and of large clinical studies in an emerging indication of [18F]FDG PET: the autoimmune encephalitis
European Journal of Nuclear Medicine and Molecular Imaging
2015
-
A Cochrane review on brain [18F]FDG PET in dementia: limitations and future perspectives
European Journal of Nuclear Medicine and Molecular Imaging
2013
-
Appropriate use criteria for amyloid PET imaging cannot replace guidelines: On behalf of the European Association of Nuclear Medicine
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 40, Núm. 7, pp. 1122-1125